|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/16 | |
| C12N 9/52 |
| (11) | Number of the document | 1701734 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05711301.1 |
| Date of filing the European patent application | 2005-01-07 | |
| (97) | Date of publication of the European application | 2006-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/000446 |
| Date | 2005-01-07 |
| (87) | Number | WO 2005/067961 |
| Date | 2005-07-28 |
| (30) | Number | Date | Country code |
| 754364 | 2004-01-08 | US |
| (72) |
BRIN, Mitchell, F., US
NAUMANN, Markus, K., DE
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | Botulinum toxin for treating vascular disorders |
| Botulinum toxin for treating vascular disorders |